|
Volumn 17, Issue 2, 2009, Pages 209-210
|
New approaches in the potential treatment of HIV-acquired immunodeficiency disease
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOVIRUS VECTOR;
CD38 ANTIGEN;
GAG PROTEIN;
GLYCOPROTEIN;
GLYCOPROTEIN TIM 3;
SIMIAN IMMUNODEFICIENCY VIRUS ANTIGEN;
T LYMPHOCYTE RECEPTOR;
UNCLASSIFIED DRUG;
VIRUS ANTIGEN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIGEN EXPRESSION;
CD4 LYMPHOCYTE COUNT;
CD8+ T LYMPHOCYTE;
DRUG EFFICACY;
DRUG SCREENING;
EDITORIAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNOMODULATION;
LYMPHOCYTE FUNCTION;
MORTALITY;
NONHUMAN;
SIMIAN IMMUNODEFICIENCY VIRUS;
VIRAL GENE DELIVERY SYSTEM;
VIRUS LOAD;
VIRUS MUTATION;
ANIMAL;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNOLOGY;
PATHOGENICITY;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANIMALS;
HIV;
HUMANS;
|
EID: 63649101151
PISSN: 15250016
EISSN: 15250024
Source Type: Journal
DOI: 10.1038/mt.2008.302 Document Type: Editorial |
Times cited : (2)
|
References (3)
|